Search:
Toggle Navigation
Search:
Our Company
About Us
Executive Team
Board of Directors
Scientific Advisors
Careers
Product Candidates
Pipeline
Collaborations
Clinical Trials
Science
Androgen Receptor Pathway
Publications
Prostate Cancer
Investors/Media
Investor Home
Press Releases
Financial Information
SEC Filings
Corporate Governance
Committee Composition
Stock Information
Analyst Coverage
Events & Presentations
Investor Contacts
Get News Alerts by Email
Contact Us
Investors/Media
Investor Home
Press Releases
Financial Information
SEC Filings
Corporate Governance
Committee Composition
Stock Information
Analyst Coverage
Events & Presentations
Investor Contacts
Get News Alerts by Email
* Required Fields
(Click here to unsubscribe)
All Alerts
Customize Alerts
Daily Closing Stock Price
Stock Price: End of Week Summary
All SEC Filings
Annual Filings
Quarterly Filings
Current Filings
Registration Statements
Section 16
Mergers & Acquisitions
Proxy & Information Statements
Other
All SEDARĀ® Filings
News Releases
Code of Conduct
Material Contracts
Other
Financial Statements
Management's Discussion & Analysis
Material Change Report
Annual Information Form
Notice of the Meeting and Record Date
Proxy Circular
Technical Report - NI 43-101
Early Warning Report
Marketing Materials
Prospectus
Documents Affecting Rights of Securityholders
Statement of Executive Compensation
Report of Exempt Distribution
NI 44-101 Notice
Annual Report
Annual Statement of Payments
Disclosure For Oil and Gas Activities NI 51-101
Notice Form 45-102F1
Issuer Bid Circular
Offering Material
Listing Application
Fund Facts / Fund Summary
Management Report of Fund Performance
Offering Memorandum
Offering Document
ETF Facts / Summary Disclosure Documents
Proxy Solicitation by Third Parties
Reports under NI 81-107
Exemptive Relief Applications
OTC Issuer filings
Take-over Bid Circular
Directors' Circular
Certificate of the annual statement of payments
Management proxy materials
Report of exempt distribution (45-106F1)
Annual financial statements
Annual MD&A
formF1
Annual certificates (52-109F1)
Interim financial statements/report
Change of auditor
Interim MD & A
Interim certificates (52-109FV2)
Technical report
Change in year end
Business acquisition report
Amended report of exempt distribution (45-106F1)
Interim certificates (52-109F2)
Exempt Issuer Bid
Report of distributions outside Canada (Form 72-503F) relying on Ontario local rule 72-503
Final
Preliminary
Amendment to preliminary
News Releases
First Name
Last Name
* Email
Company
Phone
Corporate Presentation